ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
332 hedge funds and large institutions have $6.5B invested in Intra-Cellular Therapies Inc. in 2023 Q4 according to their latest regulatory filings, with 73 funds opening new positions, 108 increasing their positions, 112 reducing their positions, and 27 closing their positions.
Holders
332
Holders Change
+41
Holders Change %
+14.09%
% of All Funds
4.87%
Holding in Top 10
10
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+25%
% of All Funds
0.15%
New
73
Increased
108
Reduced
112
Closed
27
Calls
$58.1M
Puts
$27.5M
Net Calls
+$30.6M
Net Calls Change
+$30.4M
Top Buyers
| 1 |
ACA
1
Avoro Capital Advisors
New York
|
$162M |
| 2 |
2
Morgan Stanley
New York
|
$178M |
| 3 |
3
BlackRock
New York
|
$587M |
| 4 |
4
T. Rowe Price Associates
Baltimore,
Maryland
|
$90.3M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$651M |
